#United States #Denver #Healthcare Leadership #EmVenio Research #Professional Case Management

Transforming the Future: PCM and EmVenio's Leadership Expansion

In a significant move poised to reshape the landscape of specialized home healthcare and clinical research, Professional Case Management (PCM) and its clinical research division, EmVenio Clinical Research, have introduced new executive leaders to their teams. This strategic enhancement aims to elevate their service offerings and strengthen their commitment to patient care.

On April 15, 2026, PCM's president, Greg Austin, proudly announced the appointments of Beth Perez as Chief of Staff and Sarah Zwicky as Chief Marketing Officer. This development signifies not just the expansion of leadership, but the initiation of a transformative period for the organization and its mission to provide unparalleled services to individuals with complex medical conditions.

Meet the New Leaders

Beth Perez, stepping into the role of Chief of Staff, is set to play a pivotal role in shaping the strategic direction and operational efficiency at PCM. With a robust background in healthcare consulting from the Boston Consulting Group, coupled with extensive experience across the provider and biotech sectors, Perez's leadership capabilities promise to enhance the organizational clarity and execution. Prior to joining PCM, she held executive roles at multiple organizations including DaVita Kidney Care, where she proved instrumental in crafting marketing strategies and implementing comprehensive transformation initiatives. She earned her undergraduate degree in psychology from the University of Pennsylvania and an MBA from the Tuck School of Business at Dartmouth College.

On the other hand, Sarah Zwicky brings a wealth of experience in branding and marketing, especially in dynamic and multifaceted environments. As the new Chief Marketing Officer, Zwicky is tasked with overseeing the entire marketing lifecycle for PCM and EmVenio. This includes developing brand strategies, enhancing patient engagement, and managing public affairs. Her recent tenure as the Chief Marketing and Corporate Communications Officer at EVERSANA saw her successfully lead marketing strategies through significant business growth and acquisitions, solidifying her expertise in healthcare services marketing. She holds a Bachelor of Science in Political Science from the University of Wisconsin-Madison.

A New Era for PCM and EmVenio Clinical Research

This leadership augmentation comes at a crucial time when PCM and EmVenio are poised for data-driven transformation and expanded service offerings, aimed explicitly at meeting the complex demands of their patient demographic. Austin confidently remarked, “This is a remarkable time in specialized home healthcare and clinical research. For decades, PCM and EmVenio have been at the forefront of ensuring our services address the needs of patients coping with complex clinical issues.” He further emphasized that the inclusion of Perez and Zwicky reflects a transformative moment for the company, enhancing visibility and reinforcing the positive impact on clients and patients alike.

About Professional Case Management and EmVenio Clinical Research

Founded as a premier provider of home care services, Professional Case Management specializes in providing care for nuclear weapons and uranium workers who have developed work-related illnesses. Their mission revolves around delivering supportive services that enhance the quality of life for clients, ensuring they receive care in the comfort of their homes.

EmVenio Clinical Research, a pivotal division of PCM, operates across both U.S. and European markets with a dedicated team of around 5,000 professionals. Their focus on clinical trials spans more than 90 countries, utilizing community-based sites and mobile services to broaden access for participants and enable healthcare sponsors to execute high-quality studies efficiently. EmVenio’s commitment to empathy and expert collaboration is critical in bridging the gap between scientific research and the communities served, ensuring the reflection of real-world conditions in clinical trials.

As PCM and EmVenio embark upon this new journey, the organization stands ready to adapt, innovate, and lead in providing transformative solutions within the healthcare landscape.

For ongoing updates and information, please visit EmVenio's website.